EPO and LTF were reported to show strong protein-protein interaction with collaborative anti-inflammatory properties69 and modified, optimized versions of both these proteins have been tested experimentally as neuroprotective agents in ischemic stroke and intracerebral hemorrhage, and, for some, patented (WO2006120030A1)72–74. Here, LTF is linked to ischemic stroke.